Abstract
Objectives: Angiotensin-converting enzyme inhibitors (ACEi), angiotensin II receptor blockers (ARBs), and HMG-CoA reductase inhibitors ("statins") hav......
小提示:本篇文献需要登录阅读全文,点击跳转登录